COVID-19 : Federal Updates

February 21, 2022

FDA EUA for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in adults

February 20, 2022

FDA EUA for Pfizer’s Paxlovid

January 26, 2022

FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals

January 26, 2022

FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns

December 9, 2021

FDA Antimicrobial Drugs Advisory Committee Meeting Materials (including Molnupiravir - Merck antiviral oral treatment of COVID-19)

December 9, 2021

CDC HAN: New SARS-CoV-2 Variant of Concern Identified: Omicron (B.1.1.529) Variant

September 28, 2021

FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations

September 20, 2021

President Biden's Covid-19 Action Plan (Sept. 9th 2021)

September 20, 2021

CDC HAN: Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use to Prevent or Treat COVID-19

August 23, 2021

FDA Approves First COVID-19 Vaccine

August 23, 2021

HHS Public Health and Medical Experts Joint Statement on COVID-19 Booster Shots

August 16, 2021

FDA EUA Expansion for REGEN-COV™ (casirivimab and imdevimab)

May 27, 2021

FDA EUA for Sotrovimab

April 13, 2021

Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine

January 21, 2021

Combating COVID-19 - The White House/The Biden-Harris plan

December 31, 2020

Congressional Year-End Package: What You Need to Know

December 9, 2020

FDA Safety Communication: Wear Face Masks with No Metal During MRI Exams

December 9, 2020

FDA Vaccines and Related Biological Products Announcement

November 18, 2020

FDA EUA for First COVID-19 Test for Self-Testing at Home

November 17, 2020

Fact Sheet for Health Care Providers EUA of Bamlanivimab AB

November 17, 2020

FDA EUA for Bamlanivimab

November 17, 2020

OSHA COVID-19 Guidance on Ventilation in the Workspace

September 22, 2020

FDA Publishes Comparative Performance Data for COVID-19 Molecular Diagnostic Tests

March 30, 2020

CMS Approves the Use of ED E/M Codes for Telehealth

March 26, 2020

ACEP's COVID-19 Federal & Regulatory Updates

March 24, 2020

ACEP Asks Congress to Support Emergency Physicians in COVID-19 Stimulus Package

March 23, 2020

FSMB: State Emergency Declaration Licensure Requirements COVID 19

March 23, 2020

FDA: Ventilator Supply Mitigation Strategies: Letter to Health Care Providers

March 19, 2020

FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19

March 19, 2020

CDC Guidance: Strategies for Optimizing the Supply of PPE

March 19, 2020

NIOSH: Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings

March 19, 2020

CMS Releases Recommendations on Adult Elective Surgeries, Non-Essential Medical, Surgical, and Dental Procedures During COVID-19 Response

March 18, 2020

Updated CDC Guidance: Disposition of Non-Hospitalized Patients with COVID-19

March 17, 2020

HHS Lays Out Potential Waivers, Addresses EMTALA

March 17, 2020

President Trump Expands Telehealth Benefits for Medicare Beneficiaries - Fact Sheet

March 16, 2020

COVID-19 Virtual Congressional Briefing: Reports from the Ground

March 15, 2020

OSHA Temporary Enforcement Guidance - Healthcare Respiratory Protection Annual Fit-Testing for N95 During the COVID-19 Outbreak

March 13, 2020

US Declares National Emergency

March 13, 2020

ACEP Sends Letter to HHS Secretary Outlining COVID-19 Policy Priorities